AI's September Reckoning: From Viral Design to Regulatory Chaos—The Inflection Point Nobody Saw Coming
The September 2026 AI landscape reveals a world at a crossroads: the US champions deregulation while...
Read more →Articles related to Biotechnology.
The September 2026 AI landscape reveals a world at a crossroads: the US champions deregulation while...
Read more →Neuralink’s transdural BCI expansion, China’s state-backed neural push, quantum error correction...
Read more →The U.S. Food and Drug Administration has promulgated full commercial approval for Neuralink's brain...
Read more →Japanese pharmaceutical giant Takeda has entered a strategic collaboration with Insilico Medicine, l...
Read more →In a historic June 2026 milestone, the FDA granted full approval for the world's first in-vivo CRISP...
Read more →ProteoGen, an automated machine learning system, designed a novel artificial enzyme in weeks that su...
Read more →